AUR
Price
$5.88
Change
+$0.01 (+0.17%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
10.4B
50 days until earnings call
VERA
Price
$22.19
Change
-$0.51 (-2.25%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
1.42B
58 days until earnings call
Interact to see
Advertisement

AUR vs VERA

Header iconAUR vs VERA Comparison
Open Charts AUR vs VERABanner chart's image
Aurora Innovation
Price$5.88
Change+$0.01 (+0.17%)
Volume$421.64K
Capitalization10.4B
Vera Therapeutics
Price$22.19
Change-$0.51 (-2.25%)
Volume$103.27K
Capitalization1.42B
AUR vs VERA Comparison Chart
Loading...
AUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUR vs. VERA commentary
Jun 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUR is a Hold and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2025
Stock price -- (AUR: $5.88 vs. VERA: $22.19)
Brand notoriety: AUR and VERA are both not notable
AUR represents the Information Technology Services, while VERA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUR: 99% vs. VERA: 108%
Market capitalization -- AUR: $10.4B vs. VERA: $1.42B
AUR [@Information Technology Services] is valued at $10.4B. VERA’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Information Technology Services] industry ranges from $249.89B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Information Technology Services] industry is $10.54B. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUR’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • AUR’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than AUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUR’s TA Score shows that 1 TA indicator(s) are bullish while VERA’s TA Score has 4 bullish TA indicator(s).

  • AUR’s TA Score: 1 bullish, 7 bearish.
  • VERA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VERA is a better buy in the short-term than AUR.

Price Growth

AUR (@Information Technology Services) experienced а +0.34% price change this week, while VERA (@Biotechnology) price change was -30.09% for the same time period.

The average weekly price growth across all stocks in the @Information Technology Services industry was +0.80%. For the same industry, the average monthly price growth was +4.95%, and the average quarterly price growth was +1.45%.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.17%. For the same industry, the average monthly price growth was +16.78%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

AUR is expected to report earnings on Jul 30, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Information Technology Services (+0.80% weekly)

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

@Biotechnology (+8.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUR($10.4B) has a higher market cap than VERA($1.42B). AUR YTD gains are higher at: -6.667 vs. VERA (-47.529). VERA has higher annual earnings (EBITDA): -167.77M vs. AUR (-782M). AUR has more cash in the bank: 1.16B vs. VERA (590M). VERA has less debt than AUR: VERA (54.5M) vs AUR (115M). AUR (0) and VERA (0) have equivalent revenues.
AURVERAAUR / VERA
Capitalization10.4B1.42B735%
EBITDA-782M-167.77M466%
Gain YTD-6.667-47.52914%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.16B590M196%
Total Debt115M54.5M211%
TECHNICAL ANALYSIS
Technical Analysis
AURVERA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 4 days ago
72%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EXBAX14.44N/A
N/A
Manning & Napier Pro-Blend Mod Term S
CBHCX8.55N/A
N/A
Victory Market Neutral Income C
JUSQX16.85N/A
N/A
JPMorgan US Small Company R4
JGRJX37.46N/A
N/A
JPMorgan Growth Advantage R2
VFPIX17.34N/A
N/A
Private Capital Management Value I

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with LYRA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-2.25%
LYRA - VERA
55%
Loosely correlated
-24.16%
KYMR - VERA
54%
Loosely correlated
-0.97%
BPMC - VERA
47%
Loosely correlated
+0.09%
NUVL - VERA
42%
Loosely correlated
-2.49%
CRNX - VERA
42%
Loosely correlated
-2.21%
More